Olivia joined SV Health Investors in August 2018 as Principal in the Biotechnology team based in London.
Prior to joining SV Health Investors, Olivia was a Partner at McKinsey & Company where she focused on Pharmaceuticals, Healthcare, Advanced Analytics, and Real World Evidence. Prior to that, she was a medical doctor.
Olivia holds an MBChB in Medicine and a BSc in Pharmacology from Bristol University.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557